EBR Shares EBR Systems, Inc.
WATCH ASX · ASXWireless cardiac pacing opportunity remains significant, but weaker implant data warrants cautious positioning.
Signal breakdown
- ▸Speculative buy retained after target reduction on missed implants
- ▾Below 50-day MA (-47.96%)
- ▾Near 52-week low (0.4% of range)
Is EBR a buy right now?
Trend: EBR is trading below the 50-day average (-45.65%), RSI 46 — neutral momentum, with a 3-month return of -56.90%.
Valuation & quality: EBR Systems, Inc. trades on forward P/E -1.1, price-to-book 0.97; fundamentals show net margin 0.0%, return on equity -102.5%, revenue growth 1451.2% year on year.
Analyst consensus: 4 analysts have a mean 12-month price target of A$0.96 (+666.1% vs the last close; range A$0.20 – A$1.45), consensus rating “strong buy”.
Our screen: WATCH (score 0) — Wireless cardiac pacing opportunity remains significant, but weaker implant data warrants cautious positioning.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -14.90% | +0.00% | -31.70% | -9.30% | -25.60% | -3.40% | +0.00% | -53.60% |
Fundamentals
Analyst price target
Technical signals
About EBR Systems, Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and…
Sector: Healthcare · Industry: Medical Devices · United States · 135 employees · Website
Related Health Care picks
Browse: all ASX stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.